Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Alternatives · Fidelity

Westwood Alternative Income Fund Westwood Alternative Income Fund A Class Shares (WMNAX)

Ticker WMNAX · Since 2020-03-01 · · Holdings as of Jul 31, 2026

Expense ratio
1.01%$101/yr per $10k
5-yr return
+4.3%annualized
1-yr return
+7.6%as of Dec 2025
Net assets
$180.9Mall share classes
Holdings
134

Bottom line

Is WMNAX a good fund? The bottom line

WMNAX is a share class of Westwood Alternative Income Fund, a managed alternatives mutual fund from Fidelity.

Annual fees run 1.01% — about $101 a year on every $10,000 invested, cheaper than 77% of alternatives funds we track.

It returned +7.6% over one year, +4.3% a year over five years (as of Dec 31, 2025, per its prospectus).

With $181 million in net assets and 134 holdings, its largest position is First American Funds Inc (6.5%) and the top 10 make up 26.6% of the portfolio.

This share class carries a front-end sales charge of up to 3%; a no-load class or ETF alternative can avoid it.

What stands out

  • Low cost: cheaper than 77% of alternatives peers

What to watch

  • Front-end sales load up to 3%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What WMNAX invests in

The investment objective of the Westwood Alternative Income Fund (the Fund or Alternative Income Fund) seeks to provide absolute returns through a combination of current income and capital appreciation with low correlation to equity and fixed income markets.

The Fund employs an absolute return strategy, which means that the Fund seeks to earn a positive total return through a combination of current income and capital appreciation in all market conditions, by maintaining a portfolio that is designed to have low volatility and low correlations with equity and fixed income markets over a full market cycle. In seeking to achieve its goals, the Fund invests primarily in income producing convertible securities. Convertible securities include, but are not limited to, corporate bonds, debentures, notes or preferred stocks and their hybrids that can be converted into (exchanged for) common stock or other securities, such as warrants or options, which provide an opportunity for equity participation. Once a convertible security converts to common stock, the Fund would be an equity owner of the particular company as a common stockholder. The Fund may…

From the fund's prospectus (filed Mar 5, 2026).

WMNAX performance

Average annual total returns
1 yr5 yr10 yr
WMNAX+7.6%+4.3%—
Alternatives median+7.4%+4.2%+3.8%

Source: Fund prospectus, as of Dec 31, 2025

Full WMNAX performance history →

What WMNAX costs

On a $10,000 investment, WMNAX's 1.01% expense ratio costs about $101 a year. The prospectus estimates $1,705 in total costs over 10 years (assuming 5% annual returns). The median alternatives fund charges 1.54%.

See the full WMNAX fee table →

WMNAX top 10 holdings

#Holding% of fund
1First American Funds Inc6.48%
2Welltower Op Llc2.55%
3Mks Inc2.49%
4Akamai Technologies Inc2.28%
5Ligand Pharmaceuticals Inc2.20%
6Bridgebio Pharma Inc2.20%
7Snowflake Inc2.19%
8On Semiconductor Corp2.19%
9Datadog Inc2.01%
10Microchip Technology Inc2.00%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 26.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to WMNAX

More funds like WMNAX →

WMNAX FAQ

What is the expense ratio of WMNAX?
WMNAX's expense ratio is 1.01%, which works out to about $101 a year for every $10,000 invested. The prospectus estimates total costs of $1,705 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is WMNAX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 77% of alternatives peers; front-end sales load up to 3%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does WMNAX hold?
WMNAX's largest holdings are First American Funds Inc (6.5%), Welltower Op Llc (2.5%), Mks Inc (2.5%), Akamai Technologies Inc (2.3%), Ligand Pharmaceuticals Inc (2.2%). It holds 134 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is WMNAX's 5-year return?
WMNAX returned +4.3% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Does WMNAX have a sales load?
Yes. WMNAX has a maximum front-end sales charge of 3%. It may charge a deferred sales charge of up to 1% if sold early.
Who manages WMNAX?
WMNAX is offered by Fidelity through Ultimus Managers Trust.